Immunobiography and the heterogeneity of immune responses in the elderly: A focus on inflammaging and trained immunity

Frontiers in Immunology

Volumn 8, Issue AUG, 2017, Pages

  Franceschi, Claudio ^a   Salvioli, Stefano ^b   Garagnani, Paolo ^b   de Eguileor, Magda ^c   Monti, Daniela ^d   Capri, Miriam ^b  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF INSUBRIA   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Human aging; Immunobiography; Inflammaging; Macrophages; NK cells; Trained immunity

Indexed keywords

EID: 85027836887     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00982     Document Type: Review

References (127)

1. Franceschi C, Garagnani P, Vitale G, Capri M, Salvioli S. Inflammaging and 'Garb-aging'. Trends Endocrinol Metab (2017) 28:199–212. doi:10.1016/j.tem.2016.09.005
2. Capri M, Salvioli S, Monti D, Bucci L, Garagnani P, Ottaviani E, et al. The new antigenic ecospace of the globalized world and its impact on the immune system: the battleground of trade-off and antagonistic pleiotropy. In: Malagoli D, Ottaviani E, editors. Eco-immunology: Evolutive Aspects and Future Perspectives. Netherlands: Springer (2014). p. 125–44.
3. Ottaviani E, Franceschi C. The neuroimmunology of stress from invertebrates to man. Prog Neurobiol (1996) 8:421–40. doi:10.1016/0301-0082(95)00049-6
4. Ottaviani E, Franceschi C. A new theory on the common evolutionary origin of natural immunity, inflammation and stress response: the invertebrate phagocytic immunocyte as an eye-witness. Domest Anim Endocrinol (1998) 15:291–6. doi:10.1016/S0739-7240(98)00021-6
5. Ottaviani E, Malagoli D, Franceschi C. Common evolutionary origin of the immune and neuroendocrine systems: from morphological and functional evidence to in silico approaches. Trends Immunol (2007) 28:497–502. doi:10.1016/j.it.2007.08.007
6. Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci (2000) 908:244–54. doi:10.1111/j.1749-6632.2000.tb06651.x
7. Tieri P, Grignolio A, Zaikin A, Mishto M, Remondini D, Castellani GC, et al. Network, degeneracy and bow tie. Integrating paradigms and architectures to grasp the complexity of the immune system. Theor Biol Med Model (2010) 7:32. doi:10.1186/1742-4682-7-32
8. Grignolio A, Mishto M, Faria AM, Garagnani P, Franceschi C, Tieri P. Towards a liquid self: how time, geography, and life experiences reshape the biological identity. Front Immunol (2014) 5:153. doi:10.3389/fimmu.2014. 00153
9. Liepe J, Marino F, Sidney J, Jeko A, Bunting DE, Sette A, et al. A large fraction of HLA class I ligands are proteasome-generated spliced peptides. Science (2016) 354:354–8. doi:10.1126/science.aaf4384
10. De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett (2005) 579:2035–9. doi:10.1016/j.febslet.2005.02.055
11. Ostan R, Bucci L, Capri M, Salvioli S, Scurti M, Pini E, et al. Immunosenescence and immunogenetics of human longevity. Neuroimmunomodulation (2008) 15:224–40. doi:10.1159/000156466
12. Franceschi C, Monti D, Barbieri D, Grassilli E, Troiano L, Salvioli S, et al. Immunosenescence in humans: deterioration or remodelling? Int Rev Immunol (1995) 12:57–74. doi:10.3109/08830189509056702
13. Franceschi C, Bonafè M, Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine (2000) 18:1717–20. doi:10.1016/ S0264-410X(99)00513-7
14. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev (2007) 128:92–105. doi:10.1016/j.mad.2006.11.016
15. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci (2014) 69(Suppl 1):S4–9. doi:10.1093/gerona/glu057
16. Fagiolo U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E, et al. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol (1993) 23:2375–8. doi:10.1002/eji.1830230950
17. Ferrucci L, Guralnik JM, Woodman RC, Bandinelli S, Lauretani F, Corsi AM, et al. Proinflammatory state and circulating erythropoietin in persons with and without anemia. Am J Med (2005) 118:1288. doi:10.1016/j.amjmed.2005.06.039
18. de Gonzalo-Calvo D, Neitzert K, Fernández M, Vega-Naredo I, Caballero B, García-Macía M. Differential inflammatory responses in aging and disease: TNF-alpha and IL-6 as possible biomarkers. Free Radic Biol Med (2010) 49:733–7. doi:10.1016/j.freeradbiomed.2010.05.019
19. Gerli R, Monti D, Bistoni O, Mazzone AM, Peri G, Cossarizza A, et al. Chemokines, sTNF-Rs and sCD30 serum levels in healthy aged people and centenarians. Mech Ageing Dev (2000) 121:37–46. doi:10.1016/ S0047-6374(00)00195-0
20. Mariani E, Cattini L, Neri S, Malavolta M, Mocchegiani E, Ravaglia G, et al. Simultaneous evaluation of circulating chemokine and cytokine profiles in elderly subjects by multiplex technology: relationship with zinc status. Biogerontology (2006) 7:449–59. doi:10.1007/s10522-006-9060-8
21. Seidler S, Zimmermann HW, Bartneck M, Trautwein C, Tacke F. Age dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults. BMC Immunol (2010) 11:30. doi:10.1186/1471-2172-11-30
22. Morrisette-Thomas V, Cohen AA, Fülöp T, Riesco É, Legault V, Li Q, et al. Inflamm-aging does not simply reflect increases in pro-inflammatory markers. Mech Ageing Dev (2014) 139:49–57. doi:10.1016/j.mad.2014.06.005
23. Ottaviani E, Franceschi C. The invertebrate phagocytic immunocyte: clues to a common evolution of immune and neuroendocrine systems. Immunol Today (1997) 18:169–74. doi:10.1016/S0167-5699(97)84663-4
24. Tauber AI. Metchnikoff and the phagocytosis theory. Nat Rev Mol Cell Biol (2003) 4:897–901. doi:10.1038/nrm1244
25. Coppé JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol (2010) 5:99–118. doi:10.1146/annurev-pathol-121808-102144
26. Van Deursen JM. The role of senescent cells in ageing. Nature (2014) 509:439–46. doi:10.1038/nature13193
27. Crisan TO, Netea MG, Joosten LA. Innate immune memory: implications for host responses to damage-associated molecular patterns. Eur J Immunol (2016) 46:817–28. doi:10.1002/eji.201545497
28. Bekkering S, Quintin J, Joosten LA, van der Meer JW, Netea MG, Riksen NP. Oxidized low-density lipoprotein induces longterm proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes. Arterioscler Thromb Vasc Biol (2014) 34:1731–8. doi:10.1161/ATVBAHA.114.303887
29. Valdes-Ferrer SI, Rosas-Ballina M, Olofsson PS, Lu B, Dancho ME, Li J, et al. High-mobility group box 1 mediates persistent splenocyte priming in sepsis survivors: evidence from a murine model. Shock (2013) 40:492–5. doi:10.1097/SHK.0000000000000050
30. Crisan TO, Cleophas MC, Oosting M, Lemmers H, Toenhake-Dijkstra H, Netea MG, et al. Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra. Ann Rheum Dis (2015) 75:755–62. doi:10.1136/annrheumdis-2014-206564
31. Tamburini S, Shen N, Wu HC, Clemente JC. The microbiome in early life: implications for health outcomes. Nat Med (2016) 22:713–22. doi:10.1038/ nm.4142
32. Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E, et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One (2010) 5(5):e10667. doi:10.1371/journal.pone.0010667
33. Biagi E, Franceschi C, Rampelli S, Severgnini M, Ostan R, Turroni S, et al. Gut microbiota and extreme longevity. Curr Biol (2016) 26:1480–5. doi:10.1016/j.cub.2016.04.016
34. Vatti A, Monsalve DM, Pacheco Y, Chang C, Anaya JM, Gershwin ME. Original antigenic sin: a comprehensive review. J Autoimmun (2017). doi:10.1016/j.jaut.2017.04.008
35. Netea MG, van der Meer JW. Trained immunity: an ancient way of remembering. Cell Host Microbe (2017) 21:297–300. doi:10.1016/j.chom.2017.02.003
36. Ryals JA, Neuenschwander UH, Willits MG, Molina A, Steiner HY, Hunt MD. Systemic acquired resistance. Plant Cell (1996) 8:1809–19. doi:10.1105/tpc.8.10.1809
37. Sticher L, Mauch-Mani B, Metraux JP. Systemic acquired resistance. Annu Rev Phytopathol (1997) 35:235–70. doi:10.1146/annurev.phyto.35.1.235
38. Durrant WE, Dong X. Systemic acquired resistance. Annu Rev Phytopathol (2004) 42:185–209. doi:10.1146/annurev.phyto.42.040803.140421
39. Schmid-Hempel P, Ebert D. Evolutionary parasitology: the integrated study of infections, immunology. Ecology and Genetics. New York: Oxford University Press (2013).
40. Milutinovic B, Peuss R, Ferro K, Kurtz J. Immune priming in arthropods: an update focusing on the red flour beetle. Zoology (2016) 119:254–61. doi:10.1016/j.zool.2016.03.006
41. Tettamanti G, Grimaldi A, Ferrarese R, Palazzi M, Perletti G, Valvassori R, et al. Leech responses to tissue transplantation. Tissue Cell (2003) 35:199–212. doi:10.1016/S0040-8166(03)00027-2
42. Kurtz J. Specific memory within innate immune systems. Trends Immunol (2005) 26:186–92. doi:10.1016/j.it.2005.02.001
43. Popescu LM. Telocytes – a novel type of interstitial cells. In: Braissant O, Wakamatsu H, Kuo-Kang I, Allegaert K, Lenbury Y, Wachholtz A, editors. Recent Researches in Modern Medicine. Cambridge: WSEAS Press (2011). p. 424–32.
44. Cretoiu SM, Popescu LM. Telocytes revisited. Biomol Concepts (2014) 5:353–69. doi:10.1515/bmc-2014-0029
45. Cretoiu D, Xu J, Xiao J, Cretoiu SM. Telocytes and their extracellular vesicles – evidence and hypotheses. Int J Mol Sci (2016) 17:1322. doi:10.3390/ ijms17081322
46. Stout RF Jr, Verkhratsky A, Parpura V. Caenorhabditis elegans glia modulate neuronal activity and behavior. Front Cell Neurosci (2014) 8:67. doi:10.3389/ fncel.2014.00067
47. Baranzini N, Girardello R, Grimaldi A, Ottaviani E, Pulze L, Tettamanti G, et al. Telocytes in invertebrates. Proceeding of XVIIIth scientific meeting of the Italian Association of Developmental and Comparative Immunobiology (IADCI). Invert Surv J (2017) 14:44–55.
48. Popescu LM, Manole E, Serboiu CS, Manole CG, Suciu LC, Gherghiceanu M, et al. Identification of telocytes in skeletal muscle interstitium: implication for muscle regeneration. J Cell Mol Med (2011) 15:1379–92. doi:10.1111/j.1582-4934.2011.01330.x
49. Cismaşiu VB, Popescu LM. Telocytes transfer extracellular vesicles loaded with microRNAs to stem cells. J Cell Mol Med (2015) 19:351–8. doi:10.1111/ jcmm.12529
50. Faussone-Pellegrini MS, Gherghiceanu M. Telocyte's contacts. Semin Cell Dev Biol (2016) 55:3–8. doi:10.1016/j.semcdb.2016.01.036
51. Edelstein L, Fuxe K, Levin M, Popescu BO, Smythies J. Telocytes in their context with other intercellular communication agents. Semin Cell Dev Biol (2016) 55:9–13. doi:10.1016/j.semcdb.2016.03.010
52. Edelstein L, Smythies J. Epigenetic aspects of telocytes/cordocytes: jacks of all trades, masters of most. Front Cell Neurosci (2014) 8:32. doi:10.3389/ fncel.2014.00032
53. Tribouley J, Tribouley-Duret J, Appriou M. [Effect of bacillus Callmette Guerin (BCG) on the receptivity of nude mice to Schistosoma mansoni]. C R Seances Soc Biol Fil (1978) 172:902–4.
54. Van't Wout JW, Poell R, Van Furth R. The role of BCG-PPDactivated macrophages in resistance against systemic candidiasis in mice. Scand J Immunol (1992) 36:713–9. doi:10.1111/j.1365-3083.1992.tb03132.x
55. Bistoni F, Verducci G, Perito S, Vecchiarelli A, Puccetti P, Marconi P, et al. Immunomodulation by a low-virulence, agerminative variant of Candida albicans. Further evidence for macrophage activation as one of the effector mechanisms of nonspecific anti-infectious protection. J Med Vet Mycol (1988) 26:285–99. doi:10.1080/02681218880000401
56. Klinman DM, Conover J, Coban C. Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection. Infect Immun (1999) 67:5658–63.
57. Netea MG, Quintin J, van der Meer JW. Trained immunity: a memory for innate host defense. Cell Host Microbe (2011) 9:355–61. doi:10.1016/j.chom.2011.04.006
58. Netea MG, Joosten LA, Latz E, Mills KH, Natoli G, Stunnenberg HG, et al. Trained immunity: a program of innate immune memory in health and disease. Science (2016) 352:aaf1098. doi:10.1126/science.aaf1098
59. Mbow ML, De Gregorio E, Valiante NM, Rappuoli R. New adjuvants for human vaccines. Curr Opin Immunol (2010) 22:411–6. doi:10.1016/j.coi.2010.04.004
60. Welsh RM, Selin LK. No one is naive: the significance of heterologous T-cell immunity. Nat Rev Immunol (2002) 2:417–26. doi:10.1038/nri820
61. Benn CS, Netea MG, Selin LK, Aaby P. A small jab – a big effect: nonspecific immunomodulation by vaccines. Trends Immunol (2013) 34:431–9. doi:10.1016/j.it.2013.04.004
62. Aaby P, Kollmann TR, Benn CS. Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges. Nat Immunol (2014) 15:895–9. doi:10.1038/ni.2961
63. Töpfer E, Boraschi D, Italiani P. Innate immune memory: the latest frontier of adjuvanticity. J Immunol Res (2015) 2015:478408. doi:10.1155/2015/478408
64. Quintin J, Saeed S, Martens JH, Giamarellos-Bourboulis EJ, Ifrim DC, Logie C, et al. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe (2012) 12:223–32. doi:10.1016/j.chom.2012.06.006
65. Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Jacobs C, Xavier RJ, et al. BCG-induced trained immunity in NK cells: role for non-specific protection to infection. Clin Immunol (2014) 155:213–9. doi:10.1016/j.clim.2014.10.005
66. Dou Y, Fu B, Sun R, Li W, Hu W, Tian Z, et al. Influenza vaccine induces intracellular immune memory of human NK cells. PLoS One (2015) 10:e0121258. doi:10.1371/journal.pone.0121258
67. Takeuchi A, Dejima T, Yamada H, Shibata K, Nakamura R, Eto M, et al. IL-17 production by gammadelta T cells is important for the antitumor effect of Mycobacterium bovis bacillus Calmette-Guerin treatment against bladder cancer. Eur J Immunol (2011) 41:246–51. doi:10.1002/eji.201040773
68. Fowler DW, Copier J, Wilson N, Dalgleish AG, Bodman-Smith MD. Mycobacteria activate gammadelta T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy. Cancer Immunol Immunother (2012) 61:535–47. doi:10.1007/s00262-011-1121-4
69. Saeed S, Quintin J, Kerstens HH, Rao NA, Aghajanirefah A, Matarese F, et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science (2014) 345(6204):1251086. doi:10.1126/ science.1251086
70. Cheng S, Quintin J, Cramer RA, Shepardson KM, Saeed S, Kumar V, et al. mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity. Science (2014) 345:1250684. doi:10.1126/science.1250684
71. Luna E, Ton J. The epigenetic machinery controlling transgenerational systemic acquired resistance. Plant Signal Behav (2012) 7:615–8. doi:10.4161/ psb.20155
72. Arts RJ, Joosten LA, Netea MG. Immunometabolic circuits in trained immunity. Semin Immunol (2016) 28:425–30. doi:10.1016/j.smim.2016.09.002
73. Liu TF, Vachharajani VT, Yoza BK, McCall CE. NAD+-dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response. J Biol Chem (2012) 287:25758–69. doi:10.1074/jbc.M112.362343
74. Latham T, Mackay L, Sproul D, Karim M, Culley J, Harrison DJ, et al. Lactate, a product of glycolytic metabolism, inhibits histone deacetylase activity and promotes changes in gene expression. Nucleic Acids Res (2012) 40:4794–803. doi:10.1093/nar/gks066
75. Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Ifrim DC, Saeed S, et al. Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S A (2012) 109:17537–42. doi:10.1073/pnas.1202870109
76. Burgess SL, Buonomo E, Carey M, Cowardin C, Naylor C, Noor Z, et al. Bone marrow dendritic cells from mice with an altered microbiota provide interleukin 17A-dependent protection against Entamoeba histolytica colitis. MBio (2014) 5:e01817. doi:10.1128/mBio.01817-14
77. Wen L, Duffy A. Factors influencing the gut microbiota, inflammation, and type 2 diabetes. J Nutr (2017). doi:10.3945/jn.116.240754
78. Schlums H, Cichocki F, Tesi B, Theorell J, Beziat V, Holmes TD, et al. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity (2015) 42:443–56. doi:10.1016/j.immuni.2015.02.008
79. Lee J, Zhang T, Hwang I, Kim A, Nitschke L, Kim M, et al. Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals. Immunity (2015) 42:431–42. doi:10.1016/j.immuni.2015.02.013
80. Gensous N, Bacalini MG, Pirazzini C, Marasco E, Giuliani C, Ravaioli F, et al. The epigenetic landscape of age-related diseases: the geroscience perspective. Biogerontology (2017). doi:10.1007/s10522-017-9695-7
81. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNAs biogenesis, function and decay. Nat Rev Genet (2010) 11:597–610. doi:10.1038/ nrg2843
82. O'Connell RM, Chaudhuri AA, Rao DS, Baltimore D. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci U S A (2009) 106:7113–8. doi:10.1073/pnas.0902636106
83. Olivieri F, Albertini MC, Orciani M, Ceka A, Cricca M, Procopio AD, et al. DNA damage response (DDR) and senescence: shuttled inflamma-miRNAs on the stage of inflamm-aging. Oncotarget (2015) 6:35509–21. doi:10.18632/ oncotarget.5899
84. Frasca D, Diaz A, Romero M, Ferracci F, Blomberg BB. MicroRNAs miR-155 and miR-16 decrease AID and E47 in B cells from elderly individuals. J Immunol (2015) 195(5):2134–40. doi:10.4049/jimmunol.1500520
85. Ancuta P, Rao R, Moses A, Mehle A, Shaw SK, Luscinskas FW, et al. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J Exp Med (2003) 197:1701–7. doi:10.1084/jem.20022156
86. Qian F, Wang X, Zhang L, Chen S, Piecychna M, Allore H, et al. Age-associated elevation in TLR5 leads to increased inflammatory responses in the elderly. Aging Cell (2012) 11:104–10. doi:10.1111/j.1474-9726.2011.00759.x
87. van Duin D, Mohanty S, Thomas V, Ginter S, Montgomery RR, Fikrig E, et al. Age-associated defect in human TLR-1/2 function. J Immunol (2007) 178:970–5. doi:10.4049/jimmunol.178.2.970
88. Panda A, Qian F, Mohanty S, van Duin D, Newman FK, Zhang L, et al. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol (2010) 184:2518–27. doi:10.4049/jimmunol.0901022
89. Qian F, Wang X, Zhang L, Lin A, Zhao H, Fikrig E, et al. Impaired interferon signaling in dendritic cells from older donors infected in vitro with West Nile virus. J Infect Dis (2011) 203:1415–24. doi:10.1093/infdis/jir048
90. Metcalf TU, Cubas RA, Ghneim K, Cartwright MJ, Grevenynghe JV, Richner JM, et al. Global analyses revealed age-related alterations in innate immune responses after stimulation of pathogen recognition receptors. Aging Cell (2015) 14:421–32. doi:10.1111/acel.12320
91. Dobrovolskaia MA, Vogel SN. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect (2002) 4:903–14. doi:10.1016/ S1286-4579(02)01613-1
92. Polycarpou A, Holland MJ, Karageorgiou I, Eddaoudi A, Walker SL, Willcocks S, et al. Mycobacterium leprae activates toll-like receptor-4 signaling and expression on macrophages depending on previous bacillus Calmette-Guerin vaccination. Front Cell Infect Microbiol (2016) 6:72. doi:10.3389/fcimb.2016.00072
93. Le Garff-Tavernier M, Beziat V, Decocq J, Siguret V, Gandjbakhch F, Pautas E, et al. Human NK cells display major phenotypic and functional changes over the life span. Aging Cell (2010) 9:527–35. doi:10.1111/j.1474-9726.2010.00584.x
94. Campos C, Pera A, Lopez-Fernandez I, Alonso C, Tarazona R, Solana R. Proinflammatory status influences NK cells subsets in the elderly. Immunol Lett (2014) 162:298–302. doi:10.1016/j.imlet.2014.06.015
95. Pinti M, Appay V, Campisi J, Frasca D, Fülöp T, Sauce D, et al. Aging of the immune system: focus on inflammation and vaccination. Eur J Immunol (2016) 46:2286–301. doi:10.1002/eji.201546178
96. Della Chiesa M, Marcenaro E, Sivori S, Carlomagno S, Pesce S, Moretta A. Human NK cell response to pathogens. Semin Immunol (2014) 26:152–60. doi:10.1016/j.smim.2014.02.001
97. Adib-Conquy M, Scott-Algara D, Cavaillon JM, Souza-Fonseca-Guimaraes F. TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals. Immunol Cell Biol (2014) 92:256–62. doi:10.1038/icb.2013.99
98. Chalifour A, Jeannin P, Gauchat JF, Blaecke A, Malissard M, N'Guyen T, et al. Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production. Blood (2004) 104:1778–83. doi:10.1182/blood-2003-08-2820
99. Sivori S, Falco M, Della Chiesa M, Carlomagno S, Vitale M, Moretta L, et al. CpG and double-stranded RNA trigger human NK cells by toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci U S A (2004) 101:10116–21. doi:10.1073/ pnas.0403744101
100. Hart OM, Athie-Morales V, O'Connor GM, Gardiner CM. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production. J Immunol (2005) 175:1636–42. doi:10.4049/ jimmunol.175.3.1636
101. Horton NC, Mathew PA. NKp44 and natural cytotoxicity receptors as damage-associated molecular pattern recognition receptors. Front Immunol (2015) 6:31. doi:10.3389/fimmu.2015.00031
102. Lopez-Verges S, Milush JM, Pandey S, York VA, Arakawa-Hoyt J, Pircher H, et al. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+NK-cell subset. Blood (2010) 116:3865–74. doi:10.1182/blood-2010-04-282301
103. Huntington ND, Tabarias H, Fairfax K, Brady J, Hayakawa Y, Degli-Esposti MA, et al. NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation. J Immunol (2007) 178:4764–70. doi:10.4049/jimmunol.178.8.4764
104. Muller-Durovic B, Lanna A, Polaco Covre L, Mills RS, Henson SM, Akbar AN. Killer cell lectin-like receptor G1 inhibits NK cell function through activation of adenosine 5'-monophosphate-activated protein kinase. J Immunol (2016) 197:2891–9. doi:10.4049/jimmunol.1600590
105. Kared H, Martelli S, Ng TP, Pender SL, Larbi A. CD57 in human natural killer cells and T-lymphocytes. Cancer Immunol Immunother (2016) 65:441–52. doi:10.1007/s00262-016-1803-z
106. Bjorkstrom NK, Riese P, Heuts F, Andersson S, Fauriat C, Ivarsson MA, et al. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood (2010) 116:3853–64. doi:10.1182/blood-2010-04-281675
107. Lugli E, Marcenaro E, Mavilio D. NK cell subset redistribution during the course of viral infections. Front Immunol (2014) 5:390. doi:10.3389/ fimmu.2014.00390
108. Hendricks DW, Balfour HH Jr, Dunmire SK, Schmeling DO, Hogquist KA, Lanier LL. Cutting edge: NKG2C(hi)CD57+NK cells respond specifically to acute infection with cytomegalovirus and not Epstein–Barr virus. J Immunol (2014) 192:4492–6. doi:10.4049/jimmunol.1303211
109. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature (2009) 457:557–61. doi:10.1038/nature07665
110. Heath J, Newhook N, Comeau E, Gallant M, Fudge N, Grant M. NKG2C(+) CD57(+) natural killer cell expansion parallels cytomegalovirus-specific CD8(+) T cell evolution towards senescence. J Immunol Res (2016) 2016:7470124. doi:10.1155/2016/7470124
111. Voehringer D, Koschella M, Pircher H. Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectin like receptor G1 (KLRG1). Blood (2002) 100:3698–702. doi:10.1182/blood-2002-02-0657
112. Alonso-Arias R, Moro-García MA, López-Vázquez A, Rodrigo L, Baltar J, García FM, et al. NKG2D expression in CD4+ T lymphocytes as a marker of senescence in the aged immune system. Age (Dordr) (2011) 33:591–605. doi:10.1007/s11357-010-9200-6
113. Melis L, Van Praet L, Pircher H, Venken K, Elewaut D. Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-α production by interaction with its soluble E-cadherin ligand in chronically inflamed joints. Ann Rheum Dis (2014) 73:1223–31. doi:10.1136/annrheumdis-2013-203881
114. Pereira BI, Akbar AN. Convergence of innate and adaptive immunity during human aging. Front Immunol (2016) 7:445. doi:10.3389/fimmu.2016.00445
115. Vallejo AN, Mueller RG, Hamel DL Jr, Way A, Dvergsten JA, Griffin P, et al. Expansions of NK-like alphabeta T cells with chronologic aging: novel lymphocyte effectors that compensate for functional deficits of conventional NK cells and T cells. Ageing Res Rev (2011) 10:354–61. doi:10.1016/j. arr.2010.09.006
116. Pita-López ML, Pera A, Solana R. Adaptive memory of human NK-like CD8(+) T-cells to aging, and viral and tumor antigens. Front Immunol (2016) 7:616. doi:10.3389/fimmu.2016.00616
117. Gogoi D, Dar AA, Chiplunkar SV. Involvement of notch in activation and effector functions of gammadelta T cells. J Immunol (2014) 192:2054–62. doi:10.4049/jimmunol.1300369
118. Dar AA, Patil RS, Chiplunkar SV. Insights into the relationship between Toll like receptors and gamma delta T cell responses. Front Immunol (2014) 5:366. doi:10.3389/fimmu.2014.00366
119. Argentati K, Re F, Donnini A, Tucci MG, Franceschi C, Bartozzi B, et al. Numerical and functional alterations of circulating gammadelta T lymphocytes in aged people and centenarians. J Leukoc Biol (2002) 72:65–71.
120. Roux A, Mourin G, Larsen M, Fastenackels S, Urrutia A, Gorochov G, et al. Differential impact of age and cytomegalovirus infection on the gammadelta T cell compartment. J Immunol (2013) 191:1300–6. doi:10.4049/ jimmunol.1202940
121. Wistuba-Hamprecht K, Frasca D, Blomberg B, Pawelec G, Derhovanessian E. Age-associated alterations in gammadelta T-cells are present predominantly in individuals infected with cytomegalovirus. Immun Ageing (2013) 10:26. doi:10.1186/1742-4933-10-26
122. Alejenef A, Pachnio A, Halawi M, Christmas SE, Moss PA, Khan N. Cytomegalovirus drives Vδ2neg δ T cell inflation in many healthy virus carriers with increasing age. Clin Exp Immunol (2014) 176:418–28. doi:10.1111/ cei.12297
123. Guerville F, Daburon S, Marlin R, Lartigue L, Loizon S, Pitard V, et al. TCR-dependent sensitization of human γδ T cells to non-myeloid IL-18 in cytomegalovirus and tumor stress surveillance. Oncoimmunology (2015) 4:e1003011. doi:10.1080/2162402X.2014.1003011
124. Martinez-Gonzalez I, Mathä L, Steer CA, Ghaedi M, Poon GF, Takei F. Allergen-experienced group 2 innate lymphoid cells acquire memory-like properties and enhance allergic lung inflammation. Immunity (2016) 45:198–208. doi:10.1016/j.immuni.2016.06.017
125. Fulop T, Dupuis G, Baehl S, Le Page A, Bourgade K, Frost E, et al. From inflamm-aging to immune-paralysis: a slippery slope during aging for immune adaptation. Biogerontology (2016) 17:147–57. doi:10.1007/s10522-015-9615-7
126. Christ A, Bekkering S, Latz E, Riksen NP. Long-term activation of the innate immune system in atherosclerosis. Semin Immunol (2016) 28:384–93. doi:10.1016/j.smim.2016.04.004
127. Gardiner CM, Mills KH. The cells that mediate innate immune memory and their functional significance in inflammatory and infectious diseases. Semin Immunol (2016) 28:343–50. doi:10.1016/j.smim.2016.03.001